UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 30, 2024 5:30 P.M.
Form:
F-1
CIK:
0001998311
Company Name:
APRINOIA Therapeutics Inc.
File Number:
333-276696